Table 2.
Cost (USDa) |
Effectiveness (QALYb) |
Cost-effectiveness |
||||||
---|---|---|---|---|---|---|---|---|
Country | Strategy | Health care provider cost | Household cost | Total cost | Incremental cost | HALEc | Incremental QALY | ICERd |
Malawi | Standard of care | 36·00 | 8·91 | 44·84 | 52·65 | negative | ||
PDMC Facility-delivered | 19·50 | 11·65 | 31·11 | −13·72 | 52·98 | 0·33 | negative | |
PDMC Community-delivered | 16·95 | 5·83 | 22·74 | −8·37 | 53·03 | 0·05 | dominant | |
Kenya | Standard of care | 46·63 | 29·98 | 76·40 | 53·86 | negative | ||
PDMC Facility-delivered | 26·27 | 23·47 | 51·49 | −24·91 | 54·20 | 0·34 | negative | |
PDMC Community-delivered | 22·54 | 15·72 | 37·87 | −13·61 | 54·25 | 0·05 | dominant | |
Uganda | Standard of care | 41·95 | 14·16 | 56·00 | 53·84 | negative | ||
PDMC Facility-delivered | 22·46 | 18·44 | 40·84 | −15·16 | 54·18 | 0·34 | negative | |
PDMC Community-delivered | 19·33 | 10·50 | 29·78 | −11·07 | 54·23 | 0·05 | dominant |
Incremental cost-effectiveness rankings per country. This table reports mean values from Monte-Carlo simulations of 10·000 iterations per country. Confidence intervals are shown as 95% confidence interval ellipsoids in Figures 3a-c; an extended version of this table with confidence intervals of the mean values is shown in the supplementary materials, Table S9. When comparing the three strategies, Community-delivered PDMC was the absolute dominant strategy: it was at the same time the least costly over the expected lifetime of a child (lowest cost per QALY gained) and yielded the most health-adjusted life-years. The incremental quality-adjusted life years (QALY) specify each strategy's expected impact on mortality and morbidity. The incremental values indicate that the facility-based distribution also absolutely dominates the standard of care. However, it is less cost-saving and less effective than community-based distribution when compared to standard of care.
USD– United States Dollar.
QALY– Quality-adjusted life years.
HALE– Health-adjusted life expectancy.
ICER– Incremental cost-effectiveness ratio.